Amit Bar-Or

Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis

Robert J. Fox, Amit Bar-Or, Anthony Traboulsee et al. · New England Journal of Medicine · 2025 · 111 citations · Full text

Life Sciences, Neurology, Pharmacology +13

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study

David H. Miller, Robert J. Fox, J. Theodore Phillips et al. · Neurology · 2015 · 65 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes

Omar de Faria, Qiao‐Ling Cui, Jenea M. Bin et al. · Frontiers in Genetics · 2012 · 51 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study

Amit Bar-Or, Michal Dufek, Hrvoje Budinčević et al. · The Lancet Neurology · 2025 · 21 citations · Full text

Medicine, Neurology, Pharmacology +8

MicroRNA-223 protects neurons from degeneration in Experimental Autoimmune Encephalomyelitis

Barbara Morquette, Camille A. Juźwik, Sienna Drake et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2018 · 10 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17